GFACX
Price
$57.16
Change
-$3.41 (-5.63%)
Updated
Apr 3 closing price
Net Assets
279.82B
MEGBX
Price
$110.39
Change
-$6.55 (-5.60%)
Updated
Apr 3 closing price
Net Assets
42.45B
Ad is loading...

GFACX vs MEGBX

Header iconGFACX vs MEGBX Comparison
Open Charts GFACX vs MEGBXBanner chart's image
American Funds Growth Fund of Amer C
Price$57.16
Change-$3.41 (-5.63%)
VolumeN/A
Net Assets279.82B
MFS Growth B
Price$110.39
Change-$6.55 (-5.60%)
VolumeN/A
Net Assets42.45B
GFACX vs MEGBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GFACX vs. MEGBX commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFACX is a Buy and MEGBX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 280B vs. MEGBX (42.4B). GFACX (0.00) and MEGBX (0.00) have matching dividends . GFACX was incepted earlier than MEGBX: GFACX (24 years) vs MEGBX (38 years). MEGBX (1.61) is less costly to investors than GFACX (1.36). MEGBX is a more actively managed with annual turnover of: 33.00 vs. GFACX (25.00). GFACX has a lower initial minimum investment than MEGBX: GFACX (250) vs MEGBX (1000). GFACX annual gain was more profitable for investors over the last year : -1.75 vs. MEGBX (-12.99). GFACX return over 5 years is better than : 59.73 vs. MEGBX (46.80).
GFACXMEGBXGFACX / MEGBX
Total Expense Ratio1.361.6085%
Annual Report Gross Expense Ratio1.361.6184%
Fund Existence24 years38 years-
Gain YTD-5.003-7.58766%
Front LoadN/AN/A-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets280B42.4B660%
Annual Yield % from dividends0.000.00-
Returns for 1 year-1.75-12.9913%
Returns for 3 years0.63-4.39-14%
Returns for 5 years59.7346.80128%
Returns for 10 years44.4695.6546%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OTLY9.54-0.41
-4.12%
Oatly Group AB
INDP0.47-0.03
-5.24%
Indaptus Therapeutics
VTRS8.16-0.50
-5.77%
Viatris
GDRX4.29-0.28
-6.13%
GoodRx Holdings
KOD2.40-0.27
-10.11%
Kodiak Sciences